Use of wild-typep53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53
- 1 December 1995
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 14 (4) , 275-285
- https://doi.org/10.1002/mc.2940140408
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- No room at the p53 innNature, 1993
- Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic TumorsJournal of Neuropathology and Experimental Neurology, 1993
- Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factorFEBS Letters, 1991
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.Molecular and Cellular Biology, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- HISTOCHEMICAL STAINS FOR MACROPHAGES IN CELL SMEARS AND TISSUE SECTIONS: β-GALACTOSIDASE, ACID PHOSPHATASE, NONSPECIFIC ESTERASE, SUCCINIC DEHYDROGENASE, AND CYTOCHROME OXIDASEPublished by Elsevier ,1981